Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Publication year range
1.
J Cell Physiol ; 239(2): e31164, 2024 Feb.
Article in English | MEDLINE | ID: mdl-38149816

ABSTRACT

Tumor resistance remains an obstacle to successfully treating oral squamous cell carcinoma (OSCC). Cisplatin is widely used as a cytotoxic drug to treat solid tumors, including advanced OSCC, but with low efficacy due to chemoresistance. Therefore, identifying the pathways that contribute to chemoresistance may show new possibilities for improving the treatment. This work explored the role of the tumor necrosis factor-alpha (TNF-alpha)/NFkB signaling in driving the cisplatin resistance of OSCC and its potential as a pharmacological target to overcome chemoresistance. Differential accessibility analysis demonstrated the enrichment of opened chromatin regions in members of the TNF-alpha/NFkB signaling pathway, and RNA-Seq confirmed the upregulation of TNF-alpha/NFkB signaling in cisplatin-resistant cell lines. NFkB was accumulated in cisplatin-resistant cell lines and in cancer stem cells (CSC), and the administration of TNF-alpha increased the CSC, suggesting that TNF-alpha/NFkB signaling is involved in the accumulation of CSC. TNF-alpha stimulation also increased the histone deacetylases HDAC1 and SIRT1. Cisplatin-resistant cell lines were sensitive to the pharmacological inhibition of NFkB, and low doses of the NFkB inhibitors, CBL0137, and emetine, efficiently reduced the CSC and the levels of SIRT1, increasing histone acetylation. The NFkB inhibitors decreased stemness potential, clonogenicity, migration, and invasion of cisplatin-resistant cell lines. The administration of the emetine significantly reduced the tumor growth of cisplatin-resistant xenograft models, decreasing NFkB and SIRT1, increasing histone acetylation, and decreasing CSC. TNF-alpha/NFkB/SIRT1 signaling regulates the epigenetic machinery by modulating histone acetylation, CSC, and aggressiveness of cisplatin-resistant OSCC and the NFkB inhibition is a potential strategy to treat chemoresistant OSCC.


Subject(s)
Carcinoma, Squamous Cell , Head and Neck Neoplasms , Mouth Neoplasms , Humans , Carcinoma, Squamous Cell/drug therapy , Carcinoma, Squamous Cell/genetics , Carcinoma, Squamous Cell/metabolism , Cell Line, Tumor , Cisplatin/pharmacology , Cisplatin/therapeutic use , Drug Resistance, Neoplasm , Emetine/metabolism , Emetine/therapeutic use , Head and Neck Neoplasms/drug therapy , Histones/metabolism , Mouth Neoplasms/drug therapy , Mouth Neoplasms/genetics , Mouth Neoplasms/metabolism , Neoplastic Stem Cells/pathology , Sirtuin 1/metabolism , Squamous Cell Carcinoma of Head and Neck/metabolism , Tumor Necrosis Factor-alpha/metabolism , Up-Regulation
2.
Cell Signal ; 109: 110773, 2023 09.
Article in English | MEDLINE | ID: mdl-37331417

ABSTRACT

The Wnt/ß-catenin signaling pathway is associated with the regulation of cancer stem cells, and it can be driven by epigenetic modifications. Here, we aim to identify epigenetic modifications involved in the control of the Wnt/ß-catenin signaling and investigate the role of this pathway in the accumulation of cancer stem cells (CSC) and chemoresistance of Head and Neck Squamous Cell Carcinoma (HNSCC). Quantitative-PCR, western blot, shRNA assay, viability assay, flow cytometry assay, spheres formation, xenograft model, and chromatin immunoprecipitation were employed to evaluate the Wnt/ß-catenin pathway and EZH2 in wild-type and chemoresistant oral carcinoma cell lines, and in the populations of CSC and non-stem cells. We demonstrated that ß-catenin and EZH2 were accumulated in cisplatin-resistant and CSC population. The upstream genes of the Wnt/ß-catenin signaling (APC and GSK3ß) were decreased, and the downstream gene MMP7 was increased in the chemoresistant cell lines. The inhibition of ß-catenin and EZH2 combined effectively decreased the CSC population in vitro and reduced the tumor volume and CSC population in vivo. EZH2 inhibition increased APC and GSK3ß, and the Wnt/ß-catenin inhibition reduced MMP7 levels. In contrast, EZH2 overexpression decreased APC and GSK3ß and increased MMP7. EZH2 and ß-catenin inhibitors sensitized chemoresistant cells to cisplatin. EZH2 and H3K27me3 bounded the promoter of APC, leading to its repression. These results suggest that EZH2 regulates ß-catenin by inhibiting the upstream gene APC contributing to the accumulation of cancer stem cells and chemoresistance. Moreover, the pharmacological inhibition of the Wnt/ß-catenin combined with EZH2 can be an effective strategy for treating HNSCC.


Subject(s)
Cisplatin , Head and Neck Neoplasms , Humans , Squamous Cell Carcinoma of Head and Neck/drug therapy , Cisplatin/pharmacology , Cisplatin/therapeutic use , beta Catenin/metabolism , Glycogen Synthase Kinase 3 beta/metabolism , Matrix Metalloproteinase 7/genetics , Matrix Metalloproteinase 7/metabolism , Matrix Metalloproteinase 7/pharmacology , Cell Line, Tumor , Wnt Signaling Pathway , Head and Neck Neoplasms/drug therapy , Head and Neck Neoplasms/pathology , Neoplastic Stem Cells/metabolism , Gene Expression Regulation, Neoplastic , Enhancer of Zeste Homolog 2 Protein/metabolism
3.
Arch Oral Biol ; 141: 105468, 2022 Sep.
Article in English | MEDLINE | ID: mdl-35679799

ABSTRACT

OBJECTIVES: The aims of this study were to investigate the epigenetic mechanisms and biological changes implicated in intrinsic and acquired resistance to cisplatin, a chemotherapy commonly used to treat head and neck squamous cell carcinoma. DESIGN: Intrinsic resistance (IR) was established in CAL-27 and acquired resistance (AR) in SCC-9 cell lines. Changes in the phenotype were evaluated by immunofluorescence, colony assay, invasion and spheres formation. Epigenetic regulation were assessed by quantitative PCR and western blot. RESULTS: Changes DNA damage accumulation, and a decrease of reactive oxygen species in cisplatin-resistant cell lines suggest a protection mechanism against cell death. Increases in aggressiveness, observed by clonogenic and invasive potentials, were more pronounced on the CAL-27 IR cell line. Cancer stem cells (CSC) were increased in cisplatin-resistant cells, and the administration of cisplatin increases CSC accumulation in CAL-27 IR. The loss of adhesion was noticed in CSC from IR cells. The upregulation of the genes HDAC2, HDAC9, SIRT1, KAT2B, KAT6A, KAT6B, and BRD4, the HDAC1 nuclear distribution and the decrease of the acetylated proteins H3K9, H3K36, H3K79, and H4K5 indicate that the IR mobilizes epigenetic modifications in acetylation levels, favoring the aggressiveness phenotype. Therefore, the treatment of CSC derived from CAL-27 IR with the histone deacetylase inhibitor, Vorinostat, partially recovered the CSC adhesion ability by up-regulating the levels of FAK, ß3 integrin, and Vinculin proteins. CONCLUSIONS: Our findings indicate that intrinsic-resistant cells are regulated by epigenetic modifications, which could be a potential target to treat resistant head and neck squamous cell carcinoma.


Subject(s)
Antineoplastic Agents , Carcinoma, Squamous Cell , Head and Neck Neoplasms , Antineoplastic Agents/pharmacology , Antineoplastic Agents/therapeutic use , Carcinoma, Squamous Cell/drug therapy , Carcinoma, Squamous Cell/genetics , Carcinoma, Squamous Cell/pathology , Cell Cycle Proteins/genetics , Cell Line, Tumor , Cisplatin/pharmacology , Cisplatin/therapeutic use , Epigenesis, Genetic , Head and Neck Neoplasms/drug therapy , Head and Neck Neoplasms/genetics , Head and Neck Neoplasms/pathology , Histone Acetyltransferases/genetics , Histone Acetyltransferases/metabolism , Histone Acetyltransferases/therapeutic use , Humans , Neoplastic Stem Cells/metabolism , Nuclear Proteins/metabolism , Squamous Cell Carcinoma of Head and Neck/drug therapy , Transcription Factors/genetics
4.
JBP rev. Ibero-am. odontopediatr. odontol. bebê ; 7(35): 56-64, jan.-fev. 2004. ilus
Article in Spanish, Portuguese | LILACS, BBO - Dentistry | ID: lil-405492

ABSTRACT

Este estudo teve como objetivo avaliar um programa de atenção odontológica a escolares, durante seus 10 anos de funcionamento, a fim de determinar sua eficácia e contribuição para a saúde bucal da comunidade, obtendo-se também a determinação do perfil dos pacientes atendidos. Foram selecionadas 400 fichas clínicas de crianças atendidas neste período, sendo analisados os seguintes itens: IHO (Índice de Higiene Oral), levantamento global de necessidades, procedimentos executados (curativos, preventivos, educativos, endodônticos e cirúrgicos), comportamento na primeira consulta, idade, sexo, data dos atendimentos e fator sócio-econômico e cultural. Da análise realizada, concluiu-se que a maioria das crianças era do sexo masculino e a faixa etária predominante era de 7 a 9 anos e que o comportamento dessas crianças na primeira consulta melhorou ao longo dos anos. Tanto o número de lesões cariosas iniciais e cavitadas quanto o Índice de Higiene Oral foram reduzidos. Dentre os procedimentos curativos, observou-se que a quantidade de restaurações executadas diminuiu, demonstrando menor necessidade de procedimentos invasivos. Procedimentos preventivos e educativos foram freqüentemente realizados, visando à promoção de saúde. Portanto, houve mudança de perfil dos pacientes nos últimos 10 anos, demonstrando a eficácia desse tipo de programa de atenção odontológica


Subject(s)
Humans , Male , Female , Child , Program Evaluation , Health Programs and Plans , Health Promotion , Oral Health , Critical Pathways , Health Education, Dental
SELECTION OF CITATIONS
SEARCH DETAIL
...